TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes
Abstract Tyrosine kinase 2 (TYK2), a member of the JAK family, has attracted attention as a potential therapeutic target for autoimmune diseases. However, the role of TYK2 in CD8+ T cells and autoimmune type 1 diabetes (T1D) is poorly understood. In this study, we generate Tyk2 gene knockout non-obe...
Main Authors: | Keiichiro Mine, Seiho Nagafuchi, Satoru Akazawa, Norio Abiru, Hitoe Mori, Hironori Kurisaki, Kazuya Shimoda, Yasunobu Yoshikai, Hirokazu Takahashi, Keizo Anzai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-45573-9 |
Similar Items
-
Genetic Susceptibility of the Host in Virus-Induced Diabetes
by: Keiichiro Mine, et al.
Published: (2020-07-01) -
SARS-CoV-2 Infection and Pancreatic β Cell Failure
by: Keiichiro Mine, et al.
Published: (2021-12-01) -
Regulation of Viral Infection in Diabetes
by: Seiho Nagafuchi
Published: (2021-06-01) -
In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity
by: Michaela Prchal-Murphy, et al.
Published: (2015-11-01) -
Oncogenic TYK2 P760L kinase is effectively targeted by combinatorial TYK2, mTOR and CDK4/6 kinase blockade
by: Katharina Woess, et al.
Published: (2022-01-01)